Photo of Seth Epstein

Seth Epstein

  • LABORATORY SUPERVISOR Emerging Pathogens Institute
Print ProfilePrint Profile


  • B.A., Brandeis University

  • M.D., Autonomous University of Guadalajara School of Medicine

  • Michigan Cancer Foundation

  • New York University Medical Center

  • Mount Sinai School of Medicine

  • Center for Advanced Training in Cell and Molecular Biology


  • -
    Outstanding Scientists of the 21st Century

  • -
    Dermatology Foundation, research grant

  • -
    Marquis Who's Who in America

  • -
    Marquis Who's Who in Science and Medicine

  • -
    Eye Bank Association of America Association for Research in Vision and Ophthalmology, fellowship grant


cornea, Langerhans cells, ocular herpes simplex, laser keratectomy, keratitis, herpetic eye disease


Epstein S, Jan MS, Skittone LS, Small T, Asbell PA. Evaluation of cytokine-mediated chemotaxis of Ia+ Langerhans cells (LC) into the central cornea of mice: Effect of cyclosporine A (CsA), transforming growth factor (TGF)-b and interferons (IFNs)-a, b and g. Adv Ocular Immunol 1994; 1068: 7-10.

Asbell PA, Epstein S, Wallace JW, Epstein D, Stewart CC, Burger RM. Efficacy of cobalt chelates CTC-23, CTC-67, CTC-82 and CTC-96 for treatment of ocular herpes simplex infection in a rabbit model. Cornea 1997; 17(5): 550-557.

Epstein S, Fisher EM, Sternberg GJ, Franklin W, Gordon R, Ho JJ, Asbell PA. Recurrent Ocular Herpes Simplex Keratitis Following Excimer Laser Photorefractive Keratectomy in Rabbit Model. CLAO J 2001; 27(2): 94-99.

Epstein S, Nurozler M, Smetana CR, Asbell PA. Efficacy of Polyclonal Antibodies for Treatment of Ocular Herpes Simples Infection. Cornea 2001; 20(5): 495-500.

Herpetic Disease Study Group . Predictors of Recurrent Herpes Simplex Virus Keratitis. Cornea 2001; 20(2): 123-128.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Epstein did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Annenberg Building Floor 17 Room 17-63
1468 Madison Avenue
New York, NY 10029